Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2003
|
| gptkbp:defunct |
1995
|
| gptkbp:foundedIn |
1886
|
| gptkbp:founder |
gptkb:Dr._William_E._Upjohn
|
| gptkbp:headquartersLocation |
gptkb:Kalamazoo,_Michigan,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:mergedInto |
gptkb:Pharmacia_&_Upjohn
1995 |
| gptkbp:notable_executive |
gptkb:Theodore_Cooper
gptkb:Donald_S._Gilmore gptkb:Frederick_Upjohn gptkb:Dr._William_E._Upjohn |
| gptkbp:notableBuilding |
gptkb:Upjohn_World_Headquarters
|
| gptkbp:notableEvent |
Acquisition by Pfizer in 2003
Merger with Pharmacia AB in 1995 |
| gptkbp:notableInvention |
friable pill patent
|
| gptkbp:notableProduct |
gptkb:Motrin
gptkb:Keflex gptkb:Cortisone gptkb:Halcion |
| gptkbp:numberOfEmployees |
over 8,000 (at peak)
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
gptkb:UPJ
|
| gptkbp:bfsParent |
gptkb:Kalamazoo
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Upjohn Company
|